Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Van Cott

Showing results (61-70 of 109) with videos related to

Pageof 11
Sort By:
American Journal of Clinical Pathology|April 20, 2011
Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT PlusElizabeth Lee Lewandrowski, Elizabeth M Van Cott, Kimberly Gregory, et al.
Plos One|August 4, 2017
Optical sensing of anticoagulation status: Towards point-of-care coagulation testingDiane M Tshikudi, Markandey M Tripathi, Zeinab Hajjarian, et al.
Thrombosis and Haemostasis|May 6, 2020
Differentiation of Patients with Symptomatic Low von Willebrand Factor from Those with Asymptomatic Low von Willebrand FactorEric F Grabowski, Elizabeth M Van Cott, Larissa Bornikova, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 10, 2011
Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhageArne Lauer, Frieder Schlunk, Elizabeth M Van Cott, et al.
American Journal of Hematology|July 27, 2016
Testing for dabigatran and rivaroxaban by clinical laboratoriesElizabeth M Van Cott, Kristi J Smock, Dong Chen, et al.
American Journal of Clinical Pathology|March 18, 2009
Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experienceEllinor I B Peerschke, Donna D Castellone, Marlies Ledford-Kraemer, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2020
Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTHElizabeth M Van Cott, Christelle Orlando, Gary W Moore, et al.
Journal of Thrombosis and Thrombolysis|January 30, 2014
Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC)Kazue Takahashi, Katsuki Ohtani, Mykol Larvie, et al.
Journal of Thrombosis and Haemostasis : JTH|July 19, 2019
Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTHGary W Moore, Elizabeth M Van Cott, Jacqueline A Cutler, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2018
Towards harmonization of external quality assessment/proficiency testing in hemostasisEmmanuel J Favaloro, Ian Jennings, John Olson, et al.
Pageof 11

Showing results (61-70 of 109) with videos related to

Sort By:
Pageof 11
American Journal of Clinical Pathology|April 20, 2011
Clinical evaluation of the i-STAT kaolin activated clotting time (ACT) test in different clinical settings in a large academic urban medical center: comparison with the Medtronic ACT PlusElizabeth Lee Lewandrowski, Elizabeth M Van Cott, Kimberly Gregory, et al.
Plos One|August 4, 2017
Optical sensing of anticoagulation status: Towards point-of-care coagulation testingDiane M Tshikudi, Markandey M Tripathi, Zeinab Hajjarian, et al.
Thrombosis and Haemostasis|May 6, 2020
Differentiation of Patients with Symptomatic Low von Willebrand Factor from Those with Asymptomatic Low von Willebrand FactorEric F Grabowski, Elizabeth M Van Cott, Larissa Bornikova, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 10, 2011
Antiplatelet pretreatment does not increase hematoma volume in experimental intracerebral hemorrhageArne Lauer, Frieder Schlunk, Elizabeth M Van Cott, et al.
American Journal of Hematology|July 27, 2016
Testing for dabigatran and rivaroxaban by clinical laboratoriesElizabeth M Van Cott, Kristi J Smock, Dong Chen, et al.
American Journal of Clinical Pathology|March 18, 2009
Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experienceEllinor I B Peerschke, Donna D Castellone, Marlies Ledford-Kraemer, et al.
Journal of Thrombosis and Haemostasis : JTH|January 3, 2020
Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTHElizabeth M Van Cott, Christelle Orlando, Gary W Moore, et al.
Journal of Thrombosis and Thrombolysis|January 30, 2014
Elevated plasma CL-K1 level is associated with a risk of developing disseminated intravascular coagulation (DIC)Kazue Takahashi, Katsuki Ohtani, Mykol Larvie, et al.
Journal of Thrombosis and Haemostasis : JTH|July 19, 2019
Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTHGary W Moore, Elizabeth M Van Cott, Jacqueline A Cutler, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2018
Towards harmonization of external quality assessment/proficiency testing in hemostasisEmmanuel J Favaloro, Ian Jennings, John Olson, et al.
Pageof 11